Search   
MSDS  : 1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-
CAS  : 36791-04-5
SYNONYMS  : * Icn-1229 * Ribamidyl * Ribavirin * 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide * RTCA * Viramid * Virazole
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : XZ4250000
CHEMICAL NAME : 1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-
CAS REGISTRY NUMBER : 36791-04-5
OTHER CAS REGISTRY NOS. : 66510-90-5
BEILSTEIN REFERENCE NO. : 0892462
LAST UPDATED : 199612
DATA ITEMS CITED : 32
MOLECULAR FORMULA : C8-H12-N4-O5
MOLECULAR WEIGHT : 244.24
WISWESSER LINE NOTATION : T5OTJ B1Q CQ DQ E- AT5NN DNJ CVZ
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Icn-1229
* Ribamidyl
* Ribavirin
* 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
* RTCA
* Viramid
* Virazole

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2700 mg/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent
REFERENCE :
PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation
of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1-
1967- Volume(issue)/page/year: 18,667,1984

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent
REFERENCE :
PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation
of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1-
1967- Volume(issue)/page/year: 18,667,1984

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc.,
Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC
20037) V.6- 1963- Volume(issue)/page/year: 15,1150,1972

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Unreported
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 1500 mg/kg
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
Kidney, Ureter, Bladder - other changes
Blood - hemorrhage
REFERENCE :
PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation
of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1-
1967- Volume(issue)/page/year: 18,667,1984

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 1 gm/kg/10D-I
TOXIC EFFECTS :
Blood - normocytic anemia
Blood - changes in bone marrow (not otherwise specified)
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
74,163,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - cat
DOSE/DURATION : 220 mg/kg/10D-I
TOXIC EFFECTS :
Blood - changes in platelet count
Nutritional and Gross Metabolic - changes in calcium
REFERENCE :
JVPTD9 Journal of Veterinary Pharmacology and Therapeutics. (Blackwell
Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1978-
Volume(issue)/page/year: 16,301,1993

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - cat
DOSE/DURATION : 220 mg/kg/10D-I
TOXIC EFFECTS :
Blood - changes in platelet count
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
JVPTD9 Journal of Veterinary Pharmacology and Therapeutics. (Blackwell
Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1978-
Volume(issue)/page/year: 16,301,1993

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Mammal - cat
DOSE/DURATION : 440 mg/kg/10D-I
TOXIC EFFECTS :
Blood - changes in bone marrow (not otherwise specified)
Blood - changes in platelet count
REFERENCE :
JVPTD9 Journal of Veterinary Pharmacology and Therapeutics. (Blackwell
Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1978-
Volume(issue)/page/year: 16,301,1993

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 25 mg/kg
SEX/DURATION : female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 37500 ug/kg
SEX/DURATION : female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 3150 mg/kg
SEX/DURATION : male 90 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material,
sperm morphology, motility, and count)
REFERENCE :
TSUJDP Toxic Substances Journal. (Springborn Management Consultants, 30
Springborn Center, Enfield, CT 06082) V.1- 1979-
Volume(issue)/page/year: 13,171,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 9 gm/kg
SEX/DURATION : male 60 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct
REFERENCE :
TSUJDP Toxic Substances Journal. (Springborn Management Consultants, 30
Springborn Center, Enfield, CT 06082) V.1- 1979-
Volume(issue)/page/year: 13,171,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE : 25 mg/kg
SEX/DURATION : female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
52,99,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - hamster
DOSE : 3750 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - hamster
DOSE : 2500 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 2500 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
EXMPA6 Experimental and Molecular Pathology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1962- Volume(issue)/page/year:
28,196,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 5 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
REFERENCE :
EXMPA6 Experimental and Molecular Pathology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1962- Volume(issue)/page/year:
28,196,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 2500 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - eye/ear
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 5 mg/kg
SEX/DURATION : female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - hamster
DOSE : 5 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - eye/ear
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - hamster
DOSE : 5 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 17,93,1978

** MUTATION DATA **

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 40 mg/kg/24H (Continuous)
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 224,213,1989

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Lymphocyte
DOSE/DURATION : 20 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
45,5512,1985

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - mouse Lymphocyte
DOSE/DURATION : 10 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
45,5512,1985

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 4800 ug/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
38,1771,1989

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 8600 ug/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
38,1771,1989

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 600 mg/kg/3D (Continuous)
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 224,213,1989

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 4500 mg/kg/3D (Continuous)
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year:
18,168,1991

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - rabbit Kidney
DOSE/DURATION : 1700 ug/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
38,1771,1989

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - rabbit Kidney
DOSE/DURATION : 4900 ug/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
38,1771,1989

*** REVIEWS ***

TOXICOLOGY REVIEW
JACTDZ Journal of the American College of Toxicology. (Mary Ann Liebert,
Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued.
Volume(issue)/page/year: 9(5),551,1990

*** STATUS IN U.S. ***

NIOSH Analytical Method, 1994: Ribavirin, 5027


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
1H-1,2,4-Triazole,1-((2-(2-benzofuranyl)-4,4,6-trimethyl-1,3-dioxan-2-yl)methyl)-, trans- 98519-35-8
1H-1,2,4-Triazole, 1-benzyl- 6085-94-5
1H-1,2,4-Triazole,1,5-bis(4-chlorophenyl)-3-(methylthio)- 99793-38-1
1H-1,2,4-Triazole, 3,5-bis(3,4-dimethoxyphenyl)- 107572-59-8
1H-1,2,4-Triazole,1-((bis(4-fluorophenyl)methylsilyl)methyl)- 85509-19-9
4H-1,2,4-Triazole,4,5-bis(4-methylphenyl)-3-((4-chloro-3-methylphenoxy)methyl)- 141079-06-3
4H-1,2,4-Triazole,4,5-bis(4-methylphenyl)-3-((4-methylphenoxy)methyl)- 141078-99-1
as-Triazin-3(2H)-one,5,6-bis(p-methoxyphenyl)-2-(2-(4-methyl-1-piperazinyl)ethyl)- 102486-47-5
4H-1,2,4-Triazole,3,4-bis(4-methylphenyl)-5-(phenoxymethyl)- 141078-91-3
s-Triazole, 3,5-bis(o-tolyl)- 85681-49-8
1H-1,2,4-Triazole,1-((4-bromo-2-(2,4-dichlorophenyl)tetrahydro-2-furanyl)methyl)- 116255-48-2
4H-1,2,4-Triazole, 4-butyl 16227-10-4
s-Triazole, 3-(o-butylphenyl)-5-(m-methoxyphenyl)- 85303-89-5
s-Triazole, 3-(o-butylphenyl)-5-phenyl- 85303-88-4
1H-1,2,3-Triazole-4-carbonitrile, 5-chloro- 88474-32-2
2H-1,2,3-Triazole-4-carbonitrile,5-chloro-2-(beta-D-ribofuranosyl)- 106824-88-8
1H-1,2,4-Triazole-1-carbothioamide,5-amino-3-(4-chlorophenyl)-N-methyl- 168893-29-6
2H-1,2,3-Triazole-4-carbothioamide,5-chloro-2-(beta-D-ribofuranosyl)- 106824-89-9
1,2,4-Triazin-3(2H)-one,5,6-bis(4-methoxyphenyl)-2-(3-(4-methyl-1-piperazinyl)propyl)-, dihydrochloride 84423-96-1
1H-1,2,4-Triazole-3-carboxamide,5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-,monohydrochloride, dihydrate 85815-37-8
1H-1,2,4-Triazole-1-carboxamide,3-tert-butyl-N,N-dimethyl-5-(methylthio)- 64632-00-4
1H-1,2,3-Triazole-4-carboxamide, 5-chloro- 85059-19-4
2H-1,2,3-Triazole-4-carboxamide,5-chloro-2-(beta-D-ribofuranosyl)- 106824-86-6
1,2,3-Triazole-4-carboxamide,N,N-diethyl-5-methyl-1-phenyl- 63979-27-1
1,2,3-Triazole-4-carboxamide,N,N-dimethyl-5-methyl-1-phenyl- 63979-29-3
1,2,3-Triazole-4-carboxamide,N,N-dipropyl-5-methyl-1-phenyl- 63979-30-6
1H-1,2,3-Triazole-4-carboxamide,5-methyl-1-(1-naphthalenyl)-N-phenyl- 70292-11-4
1H-1,2,3-Triazole-4-carboxamide,5-methyl-N-phenyl-1-(4-pyridinyl)- 70292-17-0
1H-1,2,3-Triazole-4-carboxamide,5-methyl-N-phenyl-1-(4-quinolinyl)- 70292-14-7
1,2,4-Triazin-3(2H)-one,5,6-bis(4-methoxyphenyl)-2-(2-(4-morpholinyl)ethyl)- 84423-87-0
1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl- 36791-04-5
1H-1,2,3-Triazole-4-carboxylic acid,5-amino-1-(1-naphthalenyl)- 70292-21-6
1H-1,2,4-Triazole-3-carboxylic acid,5-amino-1-(N,N,N',N'-tetramethyldiaminophosphinyl),ethyl ester 78371-72-9
1H-1,2,4-Triazole-3-carboxylic acid,5-amino-1-(N,N,N',N'-tetramethyldiaminophosphinyl),pentyl ester 78371-73-0
1H-1,2,4-Triazole-3-carboxylic acid,5-amino-1-(N,N,N',N'-tetramethyldiaminophosphinyl),propyl ester 78371-74-1
1H-1,2,3-Triazole-4-carboxylic acid, 5-chloro-,methyl ester 88474-33-3
2H-1,2,3-Triazole-4-carboxylic acid,5-chloro-2-(beta-D-ribofuranosyl)-, ethyl ester 106848-32-2
2H-1,2,3-Triazole-4-carboxylic acid,5-chloro-2-(beta-D-ribofuranosyl)-, methyl ester 106824-96-8
1H-1,2,4-Triazole-3-carboxylic acid,1-(2,4-dichlorophenyl)-5-(trichloromethyl)- 103112-36-3
1H-1,2,3-Triazole-4-carboxylic acid,5-methyl-1-(1-naphthalenyl)- 70292-10-3
1,2,4-Triazin-3(2H)-one,5,6-bis(4-methoxyphenyl)-2-(3-oxopentyl)- 80645-80-3
1,2,3-Triazole-4-carboxylic acid, 5-methyl-1-phenyl-,sodium salt 63979-28-2
1H-1,2,3-Triazole-4-carboxylic acid,5-methyl-1-(4-pyridinyl)- 70292-16-9
1H-1,2,3-Triazole-4-carboxylic acid,5-methyl-1-(4-quinolinyl)- 70292-13-6
1H-1,2,3-Triazole-4-carboxylic acid,5-(1-naphthalenylamino)- 70292-26-1
1H-1,2,3-Triazole-4-carboxylic acid,5-(4-pyridinylamino)- 70292-34-1
1H-1,2,4-Triazole,1-((2-(5-chloro-2-benzofuranyl)-4,5-dimethyl-1,3-dioxolan-2-yl)methyl)- 70292-34-1
1H-1,2,4-Triazole,1-((2-(5-chloro-2-benzofuranyl)-1,3-dioxan-2-yl)methyl)- 98519-07-4
1H-1,2,4-Triazole,1-((2-(5-chloro-2-benzofuranyl)-1,3-dioxolan-2-yl)methyl)- 98519-05-2
1H-1,2,4-Triazole,1-((2-(5-chloro-2-benzofuranyl)-4-(ethoxymethyl)-1,3-dioxolan-2-yl)methyl)- 98519-05-2

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net